Home › All Companies › ABT › Annual Report

ABBOTT LABORATORIES (ABT) — Annual Report

AI-Powered SEC Filing Analysis

← All ABT filings
Latest Annual Report Filed: 2026-02-20

Key Insights

  • Abbott Laboratories reported strong financial performance in 2025, with revenue growth across its key business segments including Established Pharmaceutical Products and Nutritional Products.
  • The company's profitability improved, with an increase in operating margins driven by cost optimization initiatives and favorable product mix.
  • Abbott provided a positive outlook for 2026, projecting continued revenue and earnings growth based on new product launches and expansion in emerging markets.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-20. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for ABBOTT LABORATORIES

Quarterly Report Insider Trading Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.